✦ LIBER ✦

Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density

✍ Scribed by Mark D. Hornstein; A.Albert Yuzpe; Kenneth Burry; Veasy C. Buttram Jr.; Leroy Heinrichs; Richard M. Soderstrom; Emil Steinberger; Jin-Sying Lin

Book ID: 119421964
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 722 KB
Volume: 67
Category: Article
ISSN: 1556-5653
DOI: 10.1016/s0015-0282(97)81432-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic efficacy and bone mineral de

Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)

✍ G.David Adamson; W.LeRoy Heinrichs; Milan R. Henzl; Albert A. Yuzpe; Christer Be 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Nafarelin for endometriosis: A large-sca

Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up

✍ M Elstein; K Bancroft; R Rolland; T Van der Heijden; D Barlow; S Kennedy; R Shaw 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Clinical Efficacy and Safety of Denosuma

Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis

✍ Camilla von Keyserlingk; Robert Hopkins; Athanasios Anastasilakis; Konstantinos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 698 KB

Preservation of Bone Mineral Density in

Preservation of Bone Mineral Density in Adolescents Treated with GnRH Agonists and Add-Back Therapy for Endometriosis

✍ Amy D. DiVasta; Marc R. Laufer; Catherine M. Gordon 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Increases in Hip and Spine Bone Mineral

Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate

✍ Paul D. Miller; Pierre D. Delmas; Hermann Huss; Katie M. Patel; Ralph C. Schimme 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 250 KB

Effects of bazedoxifene on bone mineral

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

✍ Akira Itabashi; Kousei Yoh; Arkadi A Chines; Takami Miki; Masahiko Takada; Hiros 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB 👁 2 views

## Abstract This randomized, double‐blind, placebo‐controlled, dose‐response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene